Gujarat Themis Biosyn Promoter's 47% Stake Fully Encumbered Indirectly

2 July 2026

Gujarat Themis Biosyn Ltd.

CTL Trusteeship (non-promoter) debenture trustee: indirect encumbrance on Target via pledge/NDU 0sh.

Recent Events

Gujarat Themis Biosyn Completes JPY 21.5 Billion MicroBiopharm Japan Acquisition

Gujarat Themis Biosyn Allots Rs 585 Crore NCDs To Fund MBJ Acquisition

Gujarat Themis Biosyn Approves ₹585 Crore Unlisted NCD Programme

Gujarat Themis Biosyn Board Approves ₹335 Crore Preferential Share Issue

Gujarat Themis Biosyn Closes ₹750 Crore QIP At ₹354 Per Share

Get features of